出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2022年10月
骨成長促進剤市場 : 製品［デバイス (外部骨成長刺激装置)、多血小板血漿］、用途 (脊椎固定手術、口腔、顎顔面手術)、エンドユーザー (病院、外来手術センター) – 2027 年までの世界予測
Bone Growth Stimulator Market by Product (Device (External Bone Growth Stimulators), Platelet-Rich Plasma), Application (Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries), End Users (Hospital, Ambulatory surgical centers) – Global Forecast to 2027
| ページ数 | 211 |
| 図表数 | 218 |
| 種別 | 英文調査報告書 |
| 価格 |
The global bone growth stimulators market is valued at an estimated USD 1.8 billion by 2027 from an estimated USD 1.4 billion in 2022, at a CAGR of 5.9% from 2022 to 2027 during forecast period.The growing demand for bone growth stimulators in spinal fusion surgeries applications; the rising preference for non-surgical and non invasive treatment.
“The bone growth stimulators devices segment accounted for the highest growth rate in the bone growth stimulation devices market, by product, during the forecast period.”
Based on product, the global bone growth stimulation devices market is segmented into External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators and Implanted Bone Growth Stimulators. In 2021, the external Bone Growth Stimulators segment accounted for the largest share of the global bone growth stimulators market. This segment is also expected to grow at the highest rate during the forecast period. The largest share of this segment can be attributed to the advantages of external devices over internal/implanted devices, these are less expensive, noninvasive, and do not require surgeries for implantation and removal which will drive the market growth.
“Spinal fusion surgeries segment accounted for the highest CAGR”
On the basis of application, the global bone growth stimulators market is segmented into – spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications. In 2021, the spinal fusion surgeries segment accounted for the largest share of the bone growth stimulators market. Factors supporting the growth increasing growing geriatric population and the rising number of spine procedures.
“The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period.”
The bone growth stimulators market is segmented into – North America, Europe, the Asia Pacific, Latin America, and Middle East and Africa. The bone growth stimulators market in several Asia-Pacific countries is expected to witness high growth during the forecast period owing to the aging population, rapid economic growth in emerging APAC countries and rising volume of spine procedures.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: Director-level–14%, C-level–10%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
Lists of Companies Profiled in the Report:
• Orthofix Medical Inc. (US)
• Enovis Coperation (US)
• ZimVie (US)
• Bioventus LLC (US)
• Medtronic plc (Ireland)
• Stryker (US)
• DePuy Synthes (US)
• Arthrex, Inc. (US)
• Isto Biologics (US)
• Terumo Corporation (Japan)
• Ember Therapeutics, Inc. (US)
• Ossatec Benelux Ltd. (Netherlands)
• Altis Biologics (Pty) Ltd. (South Africa)
• Regen Lab SA (Switzerland),
• ITO Co., Ltd. (Japan)
• Elizur Corporation (US)
• BTT Health GmbH (Germany)
• Stimulate Health (Canada)
• VQ OrthoCare (US)
• Kinex Medical Company, LLC (US)
Research Coverage
This report studies the bone growth stimulators market based on the product, application, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall bone growth stimulators market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities and challenges.
目次
1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.3 STUDY SCOPE 30
1.3.1 MARKETS COVERED 30
1.3.2 GEOGRAPHIC SCOPE 30
1.3.3 YEARS CONSIDERED 31
1.4 CURRENCY CONSIDERED 31
1.5 LIMITATIONS 31
1.6 MARKET STAKEHOLDERS 32
1.7 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 1 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Secondary sources 35
2.1.2 PRIMARY DATA 35
FIGURE 2 PRIMARY SOURCES 35
2.1.2.1 Key data from primary sources 36
2.1.2.2 Key industry insights 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND-SIDE PARTICIPANTS 37
FIGURE 4 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 38
2.2 MARKET SIZE ESTIMATION 38
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 39
2.2.1 GROWTH FORECAST 40
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40
FIGURE 7 TOP-DOWN APPROACH 41
2.3 DATA TRIANGULATION 42
FIGURE 8 DATA TRIANGULATION 42
2.4 RESEARCH ASSUMPTIONS 43
FIGURE 9 ASSUMPTIONS FOR STUDY 43
TABLE 1 INDICATORS AND ASSUMPTIONS 44
2.5 RISK ASSESSMENT 44
3 EXECUTIVE SUMMARY 45
FIGURE 10 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 45
FIGURE 11 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 46
FIGURE 12 BONE GROWTH STIMULATORS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 46
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BONE GROWTH STIMULATORS MARKET 47
4 PREMIUM INSIGHTS 48
4.1 BONE GROWTH STIMULATORS MARKET OVERVIEW 48
FIGURE 14 RISING PREVALENCE OF ORTHOPEDIC DISORDERS TO DRIVE MARKET 48
4.2 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT AND COUNTRY (2022) 49
FIGURE 15 BONE GROWTH STIMULATION DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 49
4.3 GEOGRAPHIC SNAPSHOT OF BONE GROWTH STIMULATORS MARKET 50
FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
FIGURE 17 BONE GROWTH STIMULATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
5.2.1 MARKET DRIVERS 52
5.2.1.1 Growing patient preference for noninvasive and minimally invasive surgical treatments 52
5.2.1.2 Increasing target patient population 52
5.2.1.3 Rising number of sports and accident-related orthopedic injuries 53
FIGURE 18 US: INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES (2021) 54
5.2.1.4 Rising geriatric population 54
TABLE 2 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050 55
5.2.2 MARKET RESTRAINTS 55
5.2.2.1 Limited medical reimbursement for bone stimulation products 55
5.2.2.2 High treatment costs associated with BMP and PRP products 56
5.2.2.3 Limited clinical evidence to support therapeutic efficacy of bone growth stimulators 56
5.2.3 MARKET OPPORTUNITIES 56
5.2.3.1 Emerging markets 56
5.2.3.2 Increasing use of PRP in other applications 57
5.2.3.3 Rising number of hospitals and surgical centers 57
TABLE 3 NUMBER OF ASCS AND OPERATING ROOMS, 2015–2020 58
5.2.4 MARKET CHALLENGES 58
5.2.4.1 Lack of access to diagnostics 58
5.2.4.2 Side effects associated with BMP-based orthopedic treatment 58
TABLE 4 CLINICAL SIDE EFFECTS ASSOCIATED WITH BMP-2 58
TABLE 5 PRECLINICAL SIDE EFFECTS WITH BMP-2 (IN VITRO AND IN VIVO) 59
5.3 PRICING ANALYSIS 59
TABLE 6 PRICE RANGE FOR BONE GROWTH STIMULATORS 59
5.4 VALUE CHAIN ANALYSIS 60
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 60
5.5 SUPPLY CHAIN ANALYSIS 61
5.5.1 PROMINENT COMPANIES 61
5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES 61
5.5.3 END USERS 61
FIGURE 20 BONE GROWTH STIMULATORS: SUPPLY CHAIN ANALYSIS 61
5.6 PORTER’S FIVE FORCES ANALYSIS 62
5.6.1 OVERVIEW 62
TABLE 7 BONE GROWTH STIMULATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 62
5.6.2 THREAT OF NEW ENTRANTS 62
5.6.3 THREAT OF SUBSTITUTES 62
5.6.4 BARGAINING POWER OF SUPPLIERS 62
5.6.5 BARGAINING POWER OF BUYERS 63
5.6.6 DEGREE OF COMPETITION 63
5.7 ECOSYSTEM ANALYSIS 63
TABLE 8 BONE GROWTH STIMULATORS: ROLE IN ECOSYSTEM 63
FIGURE 21 KEY PLAYERS IN BONE GROWTH STIMULATORS ECOSYSTEM 64
5.8 REGULATORY ANALYSIS 64
5.8.1 NORTH AMERICA 65
5.8.1.1 US 65
TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION 65
TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 66
5.8.1.2 Canada 66
TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67
5.8.2 EUROPE 67
5.8.3 ASIA PACIFIC 68
5.8.3.1 Japan 68
TABLE 12 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 68
5.8.3.2 China 69
TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES 69
5.8.3.3 India 70
5.9 PATENT ANALYSIS 70
5.9.1 PATENT TRENDS FOR BONE GROWTH STIMULATORS 71
FIGURE 22 PATENT ANALYSIS (JANUARY 2013–SEPTEMBER 2022) 71
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS 71
FIGURE 23 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BONE GROWTH STIMULATOR PATENTS, JANUARY 2013–SEPTEMBER 2022 72
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72
5.10.1 REVENUE SHIFT AND REVENUE POCKETS FOR BONE GROWTH STIMULATOR MANUFACTURERS 72
FIGURE 24 REVENUE SHIFT FOR BONE GROWTH STIMULATORS 73
5.11 KEY CONFERENCES AND EVENTS IN 2022–2023 73
TABLE 14 BONE GROWTH STIMULATORS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 73
5.12 TECHNOLOGY ANALYSIS 74
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 75
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 75
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BONE GROWTH STIMULATORS 75
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BONE GROWTH STIMULATORS (%) 75
5.13.2 BUYING CRITERIA 76
FIGURE 26 KEY BUYING CRITERIA FOR END USERS OF BONE GROWTH STIMULATORS 76
TABLE 16 KEY BUYING CRITERIA FOR END USERS OF BONE GROWTH STIMULATORS 76
5.14 TRADE ANALYSIS 76
5.14.1 TRADE ANALYSIS FOR BONE GROWTH STIMULATORS 76
TABLE 17 IMPORT DATA FOR BONE GROWTH STIMULATORS, BY COUNTRY, 2017–2021 (USD MILLION) 76
TABLE 18 EXPORT DATA FOR BONE GROWTH STIMULATORS, BY COUNTRY, 2017–2021 (USD MILLION) 77
6 BONE GROWTH STIMULATORS MARKET, BY PRODUCT 78
6.1 INTRODUCTION 79
TABLE 19 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 79
6.2 BONE GROWTH STIMULATION DEVICES 79
TABLE 20 BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 80
TABLE 21 BONE GROWTH STIMULATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 80
6.2.1 EXTERNAL BONE GROWTH STIMULATORS 80
TABLE 22 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 81
TABLE 23 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION) 81
6.2.1.1 Pulsed electromagnetic field devices 81
6.2.1.1.1 Pulsed electromagnetic field devices to witness highest growth in external bone growth stimulators market 81
TABLE 24 PULSED ELECTROMAGNETIC FIELD DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 82
6.2.1.2 Combined magnetic field devices 82
6.2.1.2.1 Combined magnetic field devices portable, battery-powered, and noninvasive 82
TABLE 25 COMBINED MAGNETIC FIELD DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 83
6.2.1.3 Capacitive coupling devices 83
6.2.1.3.1 Need for frequent battery replacement or recharge—disadvantage associated with CC devices 83
TABLE 26 CAPACITIVE COUPLING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 84
6.2.2 ULTRASONIC BONE GROWTH STIMULATORS 84
6.2.2.1 Used in treatment of nonunion bone fractures and failed arthrodesis 84
TABLE 27 HCPCS CODE 84
TABLE 28 ULTRASONIC BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION) 85
6.2.3 IMPLANTED BONE GROWTH STIMULATORS 85
6.2.3.1 Implanted bone growth stimulators provide constant stimulation of bone directly at fracture site 85
TABLE 29 IMPLANTED BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION) 86
6.3 BONE MORPHOGENETIC PROTEINS 86
6.3.1 SAFE AND EFFECTIVE ALTERNATIVES TO BONE GRAFTS 86
TABLE 30 BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, 2020–2027 (USD MILLION) 87
6.4 PLATELET-RICH PLASMA 87
6.4.1 ADVANTAGES OF PRP OVER OTHER PRODUCTS USED IN BONE STIMULATION TO DRIVE MARKET 87
TABLE 31 PLATELET-RICH PLASMA MARKET, BY REGION, 2020–2027 (USD MILLION) 88
7 BONE GROWTH STIMULATORS MARKET, BY APPLICATION 89
7.1 INTRODUCTION 90
TABLE 32 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 90
7.2 SPINAL FUSION SURGERIES 90
7.2.1 SPINAL FUSION SURGERIES TO DOMINATE BONE GROWTH STIMULATORS MARKET 90
TABLE 33 BONE GROWTH STIMULATORS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2020–2027 (USD MILLION) 91
7.3 DELAYED UNION AND NONUNION BONE FRACTURES 91
7.3.1 INCREASING NUMBER OF DELAYED UNION AND NONUNION BONE FRACTURES TO INCREASE DEMAND FOR BONE GROWTH STIMULATORS 91
TABLE 34 BONE GROWTH STIMULATORS MARKET FOR DELAYED UNION AND NONUNION BONE FRACTURES, BY REGION, 2020–2027 (USD MILLION) 92
7.4 ORAL AND MAXILLOFACIAL SURGERIES 92
7.4.1 BMPS USED IN ORAL AND MAXILLOFACIAL SURGERIES TO FORM BASE FOR DENTAL IMPLANTS 92
TABLE 35 BONE GROWTH STIMULATORS MARKET FOR ORAL AND MAXILLOFACIAL SURGERIES, BY REGION, 2020–2027 (USD MILLION) 93
7.5 OTHER APPLICATIONS 93
TABLE 36 BONE GROWTH STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 93
8 BONE GROWTH STIMULATORS MARKET, BY END USER 94
8.1 INTRODUCTION 95
TABLE 37 BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 95
8.2 HOSPITALS AND AMBULATORY SURGERY CENTERS 95
8.2.1 LARGEST AND FASTEST-GROWING END USERS OF BONE GROWTH STIMULATORS 95
TABLE 38 BONE GROWTH STIMULATORS MARKET FOR HOSPITALS AND ASCS, BY REGION, 2020–2027 (USD MILLION) 96
8.3 HOME CARE SETTINGS 97
8.3.1 AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE TO SUPPORT MARKET GROWTH 97
TABLE 39 BONE GROWTH STIMULATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION) 97
8.4 ACADEMIC AND RESEARCH INSTITUTES 97
8.4.1 GROWING RESEARCH ON BONE GROWTH STIMULATION PRODUCTS TO DRIVE MARKET 97
TABLE 40 BONE GROWTH STIMULATORS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 98
9 BONE GROWTH STIMULATORS MARKET, BY REGION 99
9.1 INTRODUCTION 100
TABLE 41 BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION) 100
9.2 NORTH AMERICA 100
FIGURE 27 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET SNAPSHOT 101
TABLE 42 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
TABLE 43 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 102
TABLE 44 NORTH AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 45 NORTH AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 46 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103
TABLE 47 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 104
9.2.1 US 104
9.2.1.1 High burden of sports-related injuries to drive market 104
TABLE 48 US: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 105
TABLE 49 US: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 50 US: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 106
TABLE 51 US: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106
TABLE 52 US: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 107
9.2.2 CANADA 107
9.2.2.1 Market growth driven by rising incidence of bone-related diseases 107
TABLE 53 CANADA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 108
TABLE 54 CANADA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 55 CANADA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 56 CANADA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 109
TABLE 57 CANADA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 110
9.3 EUROPE 110
TABLE 58 EUROPE: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 59 EUROPE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 111
TABLE 60 EUROPE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 61 EUROPE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 62 EUROPE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 63 EUROPE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 113
9.3.1 GERMANY 113
9.3.1.1 Largest market for bone growth stimulators in Europe 113
FIGURE 28 GERMANY: POPULATION AGED 65 AND ABOVE, 2015–2021 (MILLION) 114
TABLE 64 GERMANY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 114
TABLE 65 GERMANY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 66 GERMANY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 67 GERMANY: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 116
TABLE 68 GERMANY: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 116
9.3.2 UK 116
9.3.2.1 Increasing funding by public and private organizations to drive market 116
TABLE 69 UK: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 117
TABLE 70 UK: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 117
TABLE 71 UK: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 72 UK: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 118
TABLE 73 UK: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 119
9.3.3 FRANCE 119
9.3.3.1 Rising prevalence of diabetes to support market growth 119
TABLE 74 FRANCE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119
TABLE 75 FRANCE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 76 FRANCE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 77 FRANCE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 78 FRANCE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 121
9.3.4 ITALY 121
9.3.4.1 Increasing market availability of high-end bone growth stimulators to drive market 121
TABLE 79 ITALY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 122
TABLE 80 ITALY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 81 ITALY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 82 ITALY: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 123
TABLE 83 ITALY: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 124
9.3.5 SPAIN 124
9.3.5.1 Growing geriatric population and subsequent increase in prevalence of target conditions to drive market 124
TABLE 84 SPAIN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 125
TABLE 85 SPAIN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 86 SPAIN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 87 SPAIN: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 126
TABLE 88 SPAIN: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 127
9.3.6 REST OF EUROPE 127
TABLE 89 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 128
TABLE 90 REST OF EUROPE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 91 REST OF EUROPE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 92 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 129
TABLE 93 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 130
9.4 ASIA PACIFIC 130
FIGURE 29 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET SNAPSHOT 131
TABLE 94 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 132
TABLE 95 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 132
TABLE 96 ASIA PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 133
TABLE 97 ASIA PACIFIC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 133
TABLE 98 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 134
TABLE 99 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 134
9.4.1 JAPAN 134
9.4.1.1 Japan dominates Asia Pacific bone growth stimulators market 134
TABLE 100 JAPAN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 135
TABLE 101 JAPAN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 102 JAPAN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 103 JAPAN: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 136
TABLE 104 JAPAN: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 137
9.4.2 CHINA 137
9.4.2.1 Expansion in target patient population and modernization of healthcare facilities to drive market 137
TABLE 105 CHINA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 138
TABLE 106 CHINA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 107 CHINA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 108 CHINA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 109 CHINA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 140
9.4.3 INDIA 140
9.4.3.1 Growing number of orthopedic surgeries to support market growth 140
TABLE 110 INDIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 141
TABLE 111 INDIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 112 INDIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 113 INDIA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 114 INDIA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 143
9.4.4 AUSTRALIA 143
9.4.4.1 Availability of grants for development of advanced treatments to support market growth 143
TABLE 115 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 144
TABLE 116 AUSTRALIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 117 AUSTRALIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 118 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 146
9.4.5 SOUTH KOREA 146
9.4.5.1 Supportive government initiatives positively impact market growth 146
TABLE 120 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 146
TABLE 121 SOUTH KOREA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 122 SOUTH KOREA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 123 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 148
TABLE 124 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 148
9.4.6 REST OF ASIA PACIFIC 148
TABLE 125 GERIATRIC POPULATION, BY COUNTRY, 2015–2021 149
TABLE 126 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 149
TABLE 127 REST OF ASIA PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 128 REST OF ASIA PACIFIC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 129 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 130 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 151
9.5 LATIN AMERICA 151
TABLE 131 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 151
TABLE 132 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 152
TABLE 133 LATIN AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 134 LATIN AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 135 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 153
TABLE 136 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 154
9.5.1 BRAZIL 154
9.5.1.1 Modernization of healthcare facilities to drive market 154
TABLE 137 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 154
TABLE 138 BRAZIL: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 139 BRAZIL: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 140 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 156
TABLE 141 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 156
9.5.2 MEXICO 156
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market 156
TABLE 142 MEXICO: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 157
TABLE 143 MEXICO: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 144 MEXICO: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 145 MEXICO: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 146 MEXICO: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 159
9.5.3 REST OF LATIN AMERICA 159
TABLE 147 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 159
TABLE 148 REST OF LATIN AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 149 REST OF LATIN AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 150 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 161
TABLE 151 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 161
9.6 MIDDLE EAST AND AFRICA 161
9.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF BONE GROWTH STIMULATORS 161
TABLE 152 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 162
TABLE 153 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 154 MIDDLE EAST AND AFRICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 155 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 163
TABLE 156 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION) 164
10 COMPETITIVE LANDSCAPE 165
10.1 OVERVIEW 165
10.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN 165
TABLE 157 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BONE GROWTH STIMULATORS MARKET 165
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 166
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET 166
10.4 MARKET SHARE ANALYSIS 167
TABLE 158 BONE GROWTH STIMULATORS MARKET: DEGREE OF COMPETITION 167
10.5 COMPETITIVE LEADERSHIP MAPPING 167
10.5.1 STARS 168
10.5.2 EMERGING LEADERS 168
10.5.3 PARTICIPANTS 168
10.5.4 PERVASIVE PLAYERS 168
FIGURE 31 BONE GROWTH STIMULATORS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2021 169
10.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES 169
10.6.1 PROGRESSIVE COMPANIES 169
10.6.2 STARTING BLOCKS 169
10.6.3 RESPONSIVE COMPANIES 170
10.6.4 DYNAMIC COMPANIES 170
FIGURE 32 BONE GROWTH STIMULATORS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021 170
10.7 FOOTPRINT ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET 171
10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET 171
TABLE 159 PRODUCT FOOTPRINT OF COMPANIES 172
TABLE 160 REGIONAL FOOTPRINT OF COMPANIES 173
10.8 COMPETITIVE SCENARIO 173
10.8.1 PRODUCT LAUNCHES 174
TABLE 161 KEY PRODUCT LAUNCHES, JANUARY 2019–AUGUST 2022 174
10.8.2 DEALS 174
TABLE 162 KEY DEALS, JANUARY 2019–AUGUST 2022 174
10.8.3 OTHER DEVELOPMENTS 175
TABLE 163 OTHER KEY DEVELOPMENTS, JANUARY 2019–AUGUST 2022 175
11 COMPANY PROFILES 176
11.1 KEY PLAYERS 176
(Business overview, Products offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats)*
11.1.1 ORTHOFIX MEDICAL INC. 176
TABLE 164 ORTHOFIX MEDICAL INC.: BUSINESS OVERVIEW 176
FIGURE 33 ORTHOFIX, MEDICAL INC.: COMPANY SNAPSHOT (2021) 177
11.1.2 DEPUY SYNTHES 179
TABLE 165 DEPUY SYNTHES: BUSINESS OVERVIEW 179
FIGURE 34 DEPUY SYNTHES: COMPANY SNAPSHOT (2021) 180
11.1.3 STRYKER 183
TABLE 166 STRYKER: BUSINESS OVERVIEW 183
FIGURE 35 STRYKER: COMPANY SNAPSHOT (2021) 184
11.1.4 BIOVENTUS LLC 186
TABLE 167 BIOVENTUS LLC: BUSINESS OVERVIEW 186
FIGURE 36 BIOVENTUS LLC: COMPANY SNAPSHOT (2021) 187
11.1.5 MEDTRONIC PLC 189
TABLE 168 MEDTRONIC PLC: BUSINESS OVERVIEW 189
FIGURE 37 MEDTRONIC PLC: COMPANY SNAPSHOT (2021) 190
11.1.6 ENOVIS CORPORATION (FORMERLY COLFAX) 192
TABLE 169 ENOVIS CORPORATION (FORMERLY COLFAX): BUSINESS OVERVIEW 192
FIGURE 38 ENOVIS CORPORATION: COMPANY SNAPSHOT (2021) 193
11.1.7 ZIMVIE INC. (SUBSIDIARY OF ZIMMER BIOMET) 195
TABLE 170 ZIMVIE INC.: BUSINESS OVERVIEW 195
FIGURE 39 ZIMVIE INC.: COMPANY SNAPSHOT (2021) 195
11.1.8 ARTHREX, INC. 197
TABLE 171 ARTHREX, INC.: BUSINESS OVERVIEW 197
11.1.9 TERUMO CORPORATION 199
TABLE 172 TERUMO CORPORATION: BUSINESS OVERVIEW 199
FIGURE 40 TERUMO CORPORATION: COMPANY SNAPSHOT (2021) 200
11.1.10 OSSATEC BENELUX LTD. 201
TABLE 173 OSSATEC BENELUX LTD.: BUSINESS OVERVIEW 201
11.1.11 ISTO BIOLOGICS 202
TABLE 174 ISTO BIOLOGICS: BUSINESS OVERVIEW 202
11.1.12 EMBER THERAPEUTICS, INC. 203
TABLE 175 EMBER THERAPEUTICS, INC.: BUSINESS OVERVIEW 203
11.1.13 REGEN LAB SA 204
TABLE 176 REGEN LAB SA: BUSINESS OVERVIEW 204
11.1.14 ALTIS BIOLOGICS (PTY) LTD. 205
TABLE 177 ALTIS BIOLOGICS (PTY) LTD.: BUSINESS OVERVIEW 205
11.1.15 ITO CO., LTD. 206
TABLE 178 ITO CO., LTD.: BUSINESS OVERVIEW 206
11.2 OTHER COMPANIES 207
11.2.1 ELIZUR CORPORATION 207
11.2.2 BTT HEALTH GMBH 207
11.2.3 STIMULATE HEALTH 208
11.2.4 VQ ORTHOCARE 208
11.2.5 KINEX MEDICAL COMPANY, LLC 209
*Details on Business overview, Products offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 210
12.1 DISCUSSION GUIDE 210
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 214
12.3 CUSTOMIZATION OPTIONS 216
12.4 RELATED REPORTS 216
12.5 AUTHOR DETAILS 217